• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    MultiPlan Reports Third Quarter 2024 Results and Updates 2024 Guidance

    11/5/24 6:00:00 AM ET
    $MPLN
    Business Services
    Consumer Discretionary
    Get the next $MPLN alert in real time by email

    – Q3 2024 Revenues of $230.5 million, Net Loss of $391.5 million (including a $361.6 million impairment of goodwill and indefinite-lived intangibles), and Adjusted EBITDA of $141.6 million

    – Identified potential medical cost savings of approximately $6.4 billion in Q3 2024, up 10% from Q3 2023 and up 3% from Q2 2024

    MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading provider of data-driven cost management solutions that deliver transparency and promote fairness, quality and affordability to the U.S. healthcare industry, today reported financial results for the third quarter ended September 30, 2024 and updated its full-year 2024 guidance.

    CEO Travis Dalton said, "During the third quarter, we experienced growth in volumes of billed charges and identified potential savings. Our Revenues and Adjusted EBITDA were in line with the low end of our guidance for the third quarter. We are tightening our Revenues guidance with a modest decrease to the top end of our Adjusted EBITDA guidance for full year 2024. We anticipate the fourth quarter to run similar to our third quarter."

    "As I shared with our second quarter earnings results, I remain confident in this Company and its transformation journey. With the building of my leadership team nearly complete, this talented team has already marched forward to clearly establish the framework for developing a data and insights driven and technology focused company that is fit for growth," said Mr. Dalton.

    "With our new CFO just having completed his first 90 days at MultiPlan, we are thrilled to also welcome Tiffani Misencik into our newly created Chief Growth Officer role that is focused on our sales organization. I am extremely proud of the leadership team and talent we have been able to attract and the progress we are making. Our leaders are embedding a growth focused culture where everyone listens, problem solves and is here to serve our clients."

    Mr. Dalton concluded, "Our multi-year transformation towards a world-class data and technology company is underway. We will work with all stakeholders of the healthcare continuum to positively impact increased transparency, improved quality and lower costs. This focus will provide the platform for our long-term sustainable growth. I look forward to sharing the big mileposts of our transformation journey in the months and quarters to come."

    Business and Financial Highlights

    • Revenues of $230.5 million for Q3 2024, a decrease of 5.1%, compared to revenues of $242.8 million for Q3 2023.
    • Net loss of $391.5 million for Q3 2024, compared to net loss of $24.1 million for Q3 2023. The net loss was principally due to an impairment charge of $361.6 million for goodwill and indefinite-lived intangibles.
    • Adjusted EBITDA of $141.6 million for Q3 2024, compared to Adjusted EBITDA of $152.3 million for Q3 2023.
    • Net cash provided by operating activities of $72.8 million for Q3 2024, compared to net cash provided by operating activities of $72.1 million for Q3 2023.
    • Free Cash Flow of $41.1 million for Q3 2024, compared to Free Cash Flow of $49.7 million for Q3 2023.
    • The Company ended Q3 2024 with $86.6 million of unrestricted cash and cash equivalents on the balance sheet.
    • The Company processed approximately $44.7 billion in claim charges during Q3 2024, identifying potential medical cost savings of approximately $6.4 billion.
    • Based on the results of an impairment test as of September 30, 2024, the estimated fair values of our goodwill and indefinite-lived assets were less than their carrying value and as a result impairment charges of $355.8 million for our goodwill and $5.8 million for our indefinite-lived intangibles were recorded.

    2024 Financial Guidance

    The Company is updating certain metrics for its full-year 2024 guidance, as detailed in the table below:

    Financial Metric

     

    Prior FY 2024 Guidance

     

    Updated FY 2024 Guidance

    Revenues

     

    $935 million to $955 million

     

    $930 million to $940 million

    Adjusted EBITDA1

     

    $580 million to $595 million

     

    $580 million to $590 million

    Interest expense

     

    $320 million to $330 million

     

    (unchanged)

    Cash flow from operations

     

    $135 million to $150 million

     

    $135 million to $145 million

    Capital expenditures

     

    $120 million to $130 million

     

    (unchanged)

    Depreciation

     

    $80 million to $90 million

     

    (unchanged)

    Amortization of intangible assets

     

    $345 million to $350 million

     

    (unchanged)

    Effective tax rate

     

    25% to 28%

     

    (unchanged)

    Conference Call Information

    The Company will host a conference call today, Tuesday, November 5, 2024 at 8:30 a.m. U.S. Eastern Time (ET) to discuss its financial results. To join the conference call, please pre-register using the following link at least ten minutes before the call begins: https://www.netroadshow.com/events/login?show=95da760a&confId=71678. Upon registration, you will receive an email with the conference dial-in details and a unique access code and pin.

    A live webcast of the conference call can be accessed through the Investor Relations section of the Company's website at investors.multiplan.com/events-and-presentations. Participants should join the webcast ten minutes prior to the start of the conference call. This earnings press release and a supplemental slide deck will also be available on this section of the Company's website.

    1 We have not reconciled the forward-looking Adjusted EBITDA guidance included above to the most directly comparable GAAP (as defined below) measure because this cannot be done without unreasonable effort due to the variability and low visibility with respect to certain costs, the most significant of which are incentive compensation (including stock-based compensation), transaction-related expenses, and certain fair value measurements, which are potential adjustments to future earnings. We expect the variability of these items to have a potentially unpredictable, and a potentially significant, impact on our future GAAP financial results.

    For those unable to listen to the live conference call, a replay will be available approximately two hours after the call through the archived webcast on the Investor Relations section of the Company's website.

    About MultiPlan

    MultiPlan is committed to bending the cost curve in healthcare by delivering transparency, fairness, and affordability to the U.S. healthcare system. Our focus is on identifying medical savings, helping to lower out-of-pocket costs, and reducing or eliminating balance billing for healthcare consumers. Leveraging sophisticated technology, data analytics, and a team rich with industry experience, MultiPlan interprets customers' needs and customizes innovative solutions that combine its payment and revenue integrity, network-based, data and decision science, and analytics-based services. MultiPlan delivers value to more than 700 healthcare payors, over 100,000 employers, 60 million consumers, and 1.4 million contracted providers. For more information, visit multiplan.com.

    Forward Looking Statements

    This press release includes statements that express our management's opinions, expectations, beliefs, plans, objectives, assumptions, or projections regarding future events or future results and therefore are, or may be deemed to be, "forward-looking statements". These forward-looking statements can generally be identified by the use of forward-looking terminology, including the terms "believes," "estimates," "anticipates," "expects," "seeks," "projects," "forecasts," "intends," "plans," "may," "will," or "should" or, in each case, their negative or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. They appear in a number of places throughout this press release, including the discussion of 2024 outlook and guidance, additions to our leadership team, and the Company's ongoing transformation, and the long-term prospects of the Company. Such forward-looking statements are based on available current market information and management's expectations, beliefs and forecasts concerning future events impacting the business. Although we believe that these forward-looking statements are based on reasonable assumptions at the time they are made, you should be aware that these forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These factors include: loss of our customers, particularly our largest customers; interruptions or security breaches of our information technology systems and other cybersecurity attacks; the impact of reduced claims volumes resulting from a nationwide outage by a vendor used by our customers; the ability to achieve the goals of our strategic plans and recognize the anticipated strategic, operational, growth and efficiency benefits when expected; our ability to enter new lines of business and broaden the scope of our services; the loss of key members of management team or inability to maintain sufficient qualified personnel; our ability to continue to attract, motivate and retain a large number of skilled employees, and adapt to the effects of inflationary pressure on wages; trends in the U.S. healthcare system, including recent trends of unknown duration of reduced healthcare utilization and increased patient financial responsibility for services; effects of competition; effects of pricing pressure; our ability to identify, complete and successfully integrate acquisitions; the inability of our customers to pay for our services; changes in our industry and industry standards and technology; our ability to protect proprietary information, processes and applications; our ability to maintain the licenses or right of use for the software we use; our inability to expand our network infrastructure; our ability to obtain additional financing; our ability to pay interest and principal on our notes and other indebtedness; lowering or withdrawal of our credit ratings; adverse outcomes related to litigation or governmental proceedings; inability to preserve or increase our market share or the size of our PPO networks; decreases in discounts from providers; pressure to limit access to preferred provider networks; the loss of our existing relationships with providers; changes in our regulatory environment, including healthcare law and regulations; the expansion of privacy and security laws; heightened enforcement activity by government agencies; the possibility that we may be adversely affected by other political economic, business and/or competitive factors; changes in accounting principles or the incurrence of impairment charges our ability to remediate any material weaknesses or maintain effective internal controls over financial reporting; other factors disclosed in our Securities and Exchange Commission ("SEC") filings from time to time, including, without limitation, those factors described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023 and our filings with the SEC; and other factors beyond our control. Should one or more of these risks or uncertainties materialize, or should any of the assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements.

    There can be no assurance that future developments affecting our business will be those that we have anticipated. Forward-looking statements speak only as of the date made.

    We do not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

    Non-GAAP Financial Measures

    In addition to the financial measures prepared in accordance with generally accepted accounting principles in the United States ("GAAP"), this press release contains certain non-GAAP financial measures, including EBITDA, Adjusted EBITDA, Free Cash Flow, Unlevered Free Cash Flow and Adjusted Cash Conversion Ratio. A non-GAAP financial measure is generally defined as a numerical measure of a company's financial or operating performance that excludes or includes amounts so as to be different than the most directly comparable measure calculated and presented in accordance with GAAP.

    EBITDA, Adjusted EBITDA, Free Cash Flow, Unlevered Free Cash Flow and Adjusted Cash Conversion Ratio are supplemental measures of MultiPlan's performance that are not required by or presented in accordance with GAAP. These measures are not measurements of our financial or operating performance under GAAP, have limitations as analytical tools and should not be considered in isolation or as an alternative to net income, cash flows or any other measures of performance prepared in accordance with GAAP.

    EBITDA represents net income before interest expense, interest income, income tax provision, depreciation, amortization of intangible assets, and non-income taxes. Adjusted EBITDA is EBITDA as further adjusted by certain items as described in the table below.

    In addition, in evaluating EBITDA and Adjusted EBITDA you should be aware that, in the future, we may incur expenses similar to the adjustments in the presentation of EBITDA and Adjusted EBITDA. The presentation of EBITDA and Adjusted EBITDA should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items. The calculations of EBITDA and Adjusted EBITDA may not be comparable to similarly titled measures reported by other companies. Based on our industry and debt financing experience, we believe that EBITDA and Adjusted EBITDA are customarily used by investors, analysts and other interested parties to provide useful information regarding a company's ability to service and/or incur indebtedness.

    We also believe that Adjusted EBITDA is useful to investors and analysts in assessing our operating performance during the periods these charges were incurred on a consistent basis with the periods during which these charges were not incurred. Both EBITDA and Adjusted EBITDA have limitations as analytical tools, and you should not consider either in isolation, or as a substitute for analysis of our results as reported under GAAP. Some of the limitations are:

    • EBITDA and Adjusted EBITDA do not reflect changes in, or cash requirements for, our working capital needs;
    • EBITDA and Adjusted EBITDA do not reflect interest expense, or the cash requirements necessary to service interest or principal payments on our debt;
    • EBITDA and Adjusted EBITDA do not reflect our tax expense or the cash requirements to pay our taxes; and
    • Although depreciation and amortization are non-cash charges, the tangible assets being depreciated will often have to be replaced in the future, and EBITDA and Adjusted EBITDA do not reflect any cash requirements for such replacements.

    MultiPlan's presentation of Adjusted EBITDA should not be construed as an inference that our future results and financial position will be unaffected by unusual items.

    Free Cash Flow is defined as net cash provided by operating activities less capital expenditures, all as disclosed in the Statements of Cash Flows. Unlevered Free Cash Flow is defined as net cash provided by operating activities less capital expenditures, plus cash interest paid, all as disclosed in the Statements of Cash Flows. Free Cash Flow and Unlevered Free Cash Flow are measures of our operational performance used by management to evaluate our business after purchases of property and equipment and, in the case of Unlevered Free Cash Flow, prior to the impact of our capital structure. Free Cash Flow and Unlevered Free Cash Flow should be considered in addition to, rather than as a substitute for, consolidated net income as a measure of our performance and net cash provided by operating activities as a measure of our liquidity. Additionally, MultiPlan's definitions of Free Cash Flow and Unlevered Free Cash Flow are limited, in that they do not represent residual cash flows available for discretionary expenditures, due to the fact that the measures do not deduct the payments required for debt service, in the case of Unlevered Free Cash Flow, and other contractual obligations or payments made for business acquisitions.

    Adjusted Cash Conversion Ratio is defined as Unlevered Free Cash Flow divided by Adjusted EBITDA. MultiPlan believes that the presentation of the Adjusted Cash Conversion Ratio provides useful information to investors because it is a financial performance measure that shows how much of its Adjusted EBITDA MultiPlan converts into Unlevered Free Cash Flow.

    MULTIPLAN CORPORATION

    Unaudited Condensed Consolidated Balance Sheets

    (in thousands, except share and per share data)

     

    September 30,

    2024

     

    December 31,

    2023

    Assets

     

     

     

    Current assets:

     

     

     

    Cash and cash equivalents

    $

    86,598

     

     

    $

    71,547

     

    Restricted cash

     

    10,570

     

     

     

    9,947

     

    Trade accounts receivable, net

     

    82,132

     

     

     

    76,558

     

    Prepaid expenses

     

    16,536

     

     

     

    23,432

     

    Prepaid taxes

     

    —

     

     

     

    1,364

     

    Unbilled IDR fees, net

     

    13,975

     

     

     

    8,197

     

    Other current assets, net

     

    1,719

     

     

     

    2,548

     

    Total current assets

     

    211,530

     

     

     

    193,593

     

    Property and equipment, net

     

    292,870

     

     

     

    267,429

     

    Operating lease right-of-use assets

     

    13,572

     

     

     

    19,680

     

    Goodwill

     

    2,403,140

     

     

     

    3,829,002

     

    Other intangibles, net

     

    2,366,794

     

     

     

    2,633,207

     

    Other assets, net

     

    31,298

     

     

     

    21,776

     

    Total assets

    $

    5,319,204

     

     

    $

    6,964,687

     

    Liabilities and Shareholders' Equity

     

     

     

    Current liabilities:

     

     

     

    Accounts payable

    $

    22,547

     

     

    $

    19,590

     

    Accrued interest

     

    74,314

     

     

     

    56,827

     

    Accrued taxes

     

    8,123

     

     

     

    —

     

    Operating lease obligation, short-term

     

    4,585

     

     

     

    4,792

     

    Current portion of long-term debt

     

    13,250

     

     

     

    13,250

     

    Accrued compensation

     

    33,624

     

     

     

    44,720

     

    Accrued legal contingencies

     

    23,123

     

     

     

    12,123

     

    Other accrued expenses

     

    21,931

     

     

     

    15,437

     

    Total current liabilities

     

    201,497

     

     

     

    166,739

     

    Long-term debt

     

    4,510,245

     

     

     

    4,532,733

     

    Operating lease obligation, long-term

     

    9,716

     

     

     

    17,124

     

    Private Placement Warrants and Unvested Founder Shares

     

    1

     

     

     

    477

     

    Deferred income taxes

     

    378,508

     

     

     

    521,707

     

    Other liabilities

     

    11,675

     

     

     

    16,783

     

    Total liabilities

     

    5,111,642

     

     

     

    5,255,563

     

    Shareholders' equity:

     

     

     

    Shareholder interests

     

     

     

    Preferred stock, $0.0001 par value — 10,000,000 shares authorized; no shares issued

     

    —

     

     

     

    —

     

    Common stock, $0.0001 par value — 1,500,000,000 shares authorized; 16,914,056 and 16,695,207 issued; 16,171,197 and 16,207,984 shares outstanding(1)

     

    2

     

     

     

    2

     

    Additional paid-in capital(1)

     

    2,365,928

     

     

     

    2,348,570

     

    Accumulated other comprehensive loss

     

    (12,462

    )

     

     

    (11,778

    )

    Retained deficit

     

    (2,007,173

    )

     

     

    (499,307

    )

    Treasury stock — 742,859 and 487,223 shares(1)

     

    (138,733

    )

     

     

    (128,363

    )

    Total shareholders' equity

     

    207,562

     

     

     

    1,709,124

     

    Total liabilities and shareholders' equity

    $

    5,319,204

     

     

    $

    6,964,687

     

    (1)Shares, common stock and additional paid-in capital have been retroactively adjusted for all periods presented to reflect the one-for-forty (1-for-40) reverse stock split that became effective on September 20, 2024.

    MULTIPLAN CORPORATION

    Unaudited Condensed Consolidated Statements of Loss and Comprehensive Loss

    (in thousands, except share and per share data)

     

    Three Months Ended September 30,

     

    Nine Months Ended September 30,

     

     

    2024

     

     

     

    2023

     

     

     

    2024

     

     

     

    2023

     

    Revenues

    $

    230,495

     

     

    $

    242,804

     

     

    $

    698,479

     

     

    $

    717,389

     

    Costs of services (exclusive of depreciation and amortization of intangible assets shown below)

     

    60,825

     

     

     

    60,949

     

     

     

    182,271

     

     

     

    174,806

     

    General and administrative expenses

     

    37,725

     

     

     

    36,779

     

     

     

    107,133

     

     

     

    107,996

     

    Depreciation

     

    22,572

     

     

     

    19,586

     

     

     

    65,372

     

     

     

    56,693

     

    Amortization of intangible assets

     

    85,971

     

     

     

    85,971

     

     

     

    257,913

     

     

     

    256,724

     

    Loss on impairment of goodwill and intangible assets

     

    361,612

     

     

     

    —

     

     

     

    1,434,363

     

     

     

    —

     

    Total expenses

     

    568,705

     

     

     

    203,285

     

     

     

    2,047,052

     

     

     

    596,219

     

    Operating (loss) income

     

    (338,210

    )

     

     

    39,519

     

     

     

    (1,348,573

    )

     

     

    121,170

     

    Interest expense

     

    81,792

     

     

     

    84,300

     

     

     

    245,119

     

     

     

    250,203

     

    Interest income

     

    (1,245

    )

     

     

    (1,505

    )

     

     

    (2,722

    )

     

     

    (7,110

    )

    Gain on extinguishment of debt

     

    —

     

     

     

    (10,129

    )

     

     

    (5,913

    )

     

     

    (46,907

    )

    (Gain) loss on change in fair value of Private Placement Warrants and Unvested Founder Shares

     

    (87

    )

     

     

    (2,127

    )

     

     

    (476

    )

     

     

    267

     

    Net loss before taxes

     

    (418,670

    )

     

     

    (31,020

    )

     

     

    (1,584,581

    )

     

     

    (75,283

    )

    Benefit for income taxes

     

    (27,220

    )

     

     

    (6,875

    )

     

     

    (76,715

    )

     

     

    (14,977

    )

    Net loss

    $

    (391,450

    )

     

    $

    (24,145

    )

     

    $

    (1,507,866

    )

     

    $

    (60,306

    )

     

     

     

     

     

     

     

     

    Weighted average shares outstanding – Basic(1)

     

    16,143,520

     

     

     

    16,161,095

     

     

     

    16,139,523

     

     

     

    16,096,395

     

    Weighted average shares outstanding – Diluted(1)

     

    16,143,520

     

     

     

    16,161,095

     

     

     

    16,139,523

     

     

     

    16,096,395

     

     

     

     

     

     

     

     

     

    Net loss per share – Basic(1)

    $

    (24.25

    )

     

    $

    (1.49

    )

     

    $

    (93.43

    )

     

    $

    (3.75

    )

    Net loss per share – Diluted(1)

    $

    (24.25

    )

     

    $

    (1.49

    )

     

    $

    (93.43

    )

     

    $

    (3.75

    )

     

     

     

     

     

     

     

     

    Net loss

     

    (391,450

    )

     

     

    (24,145

    )

     

     

    (1,507,866

    )

     

     

    (60,306

    )

    Other comprehensive income:

     

     

     

     

     

     

     

    Change in unrealized gains (losses) on interest rate swaps, net of tax

     

    (11,341

    )

     

     

    382

     

     

     

    (684

    )

     

     

    382

     

    Comprehensive loss

    $

    (402,791

    )

     

    $

    (23,763

    )

     

    $

    (1,508,550

    )

     

    $

    (59,924

    )

    (1)Shares and net loss per share have been retroactively adjusted for all periods presented to reflect the one-for-forty (1-for-40) reverse stock split that became effective on September 20, 2024.

    MULTIPLAN CORPORATION

    Unaudited Condensed Consolidated Statements of Cash Flows

    (in thousands)

     

    Nine Months Ended September 30,

     

     

    2024

     

     

     

    2023

     

    Operating activities:

     

     

     

    Net loss

    $

    (1,507,866

    )

     

    $

    (60,306

    )

    Adjustments to reconcile net income to net cash provided by operating activities:

     

     

     

    Depreciation

     

    65,372

     

     

     

    56,693

     

    Amortization of intangible assets

     

    257,913

     

     

     

    256,724

     

    Amortization of the right-of-use asset

     

    3,377

     

     

     

    4,329

     

    Loss on impairment of goodwill and intangible assets

     

    1,434,363

     

     

     

    —

     

    Stock-based compensation

     

    19,829

     

     

     

    13,357

     

    Deferred income taxes

     

    (142,999

    )

     

     

    (87,278

    )

    Amortization of debt issuance costs and discounts

     

    8,788

     

     

     

    7,967

     

    Gain on extinguishment of debt

     

    (5,913

    )

     

     

    (46,907

    )

    Loss on disposal of property and equipment

     

    155

     

     

     

    452

     

    (Gain) loss on change in fair value of Private Placement Warrants and Unvested Founder Shares

     

    (476

    )

     

     

    267

     

    Changes in assets and liabilities:

     

     

     

    Accounts receivable, net

     

    (5,574

    )

     

     

    11,621

     

    Prepaid expenses and other assets

     

    (9,466

    )

     

     

    (759

    )

    Prepaid taxes

     

    1,364

     

     

     

    (5,224

    )

    Operating lease obligation

     

    (4,884

    )

     

     

    (5,041

    )

    Accounts payable, accrued interest, accrued taxes, accrued expenses, legal contingencies and other

     

    27,046

     

     

     

    (1,877

    )

    Net cash provided by operating activities

     

    141,029

     

     

     

    144,018

     

    Investing activities:

     

     

     

    Purchases of property and equipment

     

    (87,689

    )

     

     

    (77,509

    )

    BST Acquisition, net of cash acquired

     

    —

     

     

     

    (140,940

    )

    Net cash used in investing activities

     

    (87,689

    )

     

     

    (218,449

    )

    Financing activities:

     

     

     

    Repurchase of 5.750% Notes

     

    —

     

     

     

    (134,975

    )

    Repayments of Term Loan B

     

    (9,938

    )

     

     

    (9,938

    )

    Repurchase of Senior Convertible PIK Notes

     

    (14,886

    )

     

     

    —

     

    Taxes paid on settlement of vested share awards

     

    (3,355

    )

     

     

    (461

    )

    Purchase of treasury stock

     

    (10,370

    )

     

     

    (13,140

    )

    Proceeds from issuance of common stock under Employee Stock Purchase Plan

     

    883

     

     

     

    —

     

    Net cash used in financing activities

     

    (37,666

    )

     

     

    (158,514

    )

    Net increase (decrease) in cash, cash equivalents and restricted cash

     

    15,674

     

     

     

    (232,945

    )

    Cash, cash equivalents and restricted cash at beginning of period

     

    81,494

     

     

     

    340,559

     

    Cash, cash equivalents and restricted cash at end of period

    $

    97,168

     

     

    $

    107,614

     

     

     

     

     

    Cash and cash equivalents

    $

    86,598

     

     

    $

    101,320

     

    Restricted cash

     

    10,570

     

     

     

    6,294

     

    Cash, cash equivalents and restricted cash at end of period

    $

    97,168

     

     

    $

    107,614

     

     

     

     

     

    Noncash investing and financing activities:

     

     

     

    Purchases of property and equipment not yet paid

    $

    11,928

     

     

    $

    7,319

     

    Supplemental disclosure of cash flow information:

     

     

     

    Cash paid during the period for:

     

     

     

    Interest

    $

    (218,590

    )

     

    $

    (223,640

    )

    Income taxes, net of refunds

    $

    (57,860

    )

     

    $

    (78,582

    )

    MULTIPLAN CORPORATION

    Calculation of EBITDA and Adjusted EBITDA

     

     

    Three Months Ended September 30,

     

    Nine Months Ended September 30,

    (in thousands)

     

    2024

     

     

     

    2023

     

     

     

    2024

     

     

     

    2023

     

     

     

     

     

     

     

     

     

    Net loss

    $

    (391,450

    )

     

    $

    (24,145

    )

     

    $

    (1,507,866

    )

     

    $

    (60,306

    )

    Adjustments:

     

     

     

     

     

     

     

    Interest expense

     

    81,792

     

     

     

    84,300

     

     

     

    245,119

     

     

     

    250,203

     

    Interest income

     

    (1,245

    )

     

     

    (1,505

    )

     

     

    (2,722

    )

     

     

    (7,110

    )

    Benefit for income taxes

     

    (27,220

    )

     

     

    (6,875

    )

     

     

    (76,715

    )

     

     

    (14,977

    )

    Depreciation

     

    22,572

     

     

     

    19,586

     

     

     

    65,372

     

     

     

    56,693

     

    Amortization of intangible assets

     

    85,971

     

     

     

    85,971

     

     

     

    257,913

     

     

     

    256,724

     

    Non-income taxes

     

    515

     

     

     

    669

     

     

     

    1,623

     

     

     

    1,672

     

    EBITDA

    $

    (229,065

    )

     

    $

    158,001

     

     

    $

    (1,017,276

    )

     

    $

    482,899

     

    Adjustments:

     

     

     

     

     

     

     

    Other expenses (income), net(1)

     

    1,517

     

     

     

    521

     

     

     

    2,584

     

     

     

    759

     

    Integration expenses

     

    850

     

     

     

    891

     

     

     

    1,994

     

     

     

    2,722

     

    Change in fair value of Private Placement Warrants and unvested founder shares

     

    (87

    )

     

     

    (2,127

    )

     

     

    (476

    )

     

     

    267

     

    Transaction-related expenses

     

    —

     

     

     

    269

     

     

     

    —

     

     

     

    8,105

     

    Gain on extinguishment of debt

     

    —

     

     

     

    (10,129

    )

     

     

    (5,913

    )

     

     

    (46,907

    )

    Loss on impairment of goodwill and intangible assets

     

    361,612

     

     

     

    —

     

     

     

    1,434,363

     

     

     

    —

     

    Stock-based compensation

     

    6,818

     

     

     

    4,835

     

     

     

    19,829

     

     

     

    13,357

     

    Adjusted EBITDA

    $

    141,645

     

     

    $

    152,261

     

     

    $

    435,105

     

     

    $

    461,202

     

    (1) "Other expenses (income), net" represent miscellaneous non-recurring income, miscellaneous non-recurring expense, gain or loss on disposal of assets, impairment of other assets, gain or loss on disposal of leases, tax penalties, and non-integration related severance costs.

    Calculation of Unlevered Free Cash Flow and Adjusted Cash Conversion Ratio

     

    Three Months Ended September 30,

     

    Nine Months Ended September 30,

    (in thousands)

     

    2024

     

     

     

    2023

     

     

     

    2024

     

     

     

    2023

     

     

     

     

     

     

     

     

     

    Net cash provided by operating activities

    $

    72,842

     

     

    $

    72,118

     

     

    $

    141,029

     

     

    $

    144,018

     

    Purchases of property and equipment

     

    (31,700

    )

     

     

    (22,414

    )

     

     

    (87,689

    )

     

     

    (77,509

    )

    Free Cash Flow

     

    41,142

     

     

     

    49,704

     

     

     

    53,340

     

     

     

    66,509

     

    Interest paid

     

    60,195

     

     

     

    62,156

     

     

     

    218,590

     

     

     

    223,640

     

    Unlevered Free Cash Flow

    $

    101,337

     

     

    $

    111,860

     

     

    $

    271,930

     

     

    $

    290,149

     

     

     

     

     

     

     

     

     

    Adjusted EBITDA

    $

    141,645

     

     

    $

    152,261

     

     

    $

    435,105

     

     

    $

    461,202

     

    Adjusted Cash Conversion Ratio

     

    72

    %

     

     

    73

    %

     

     

    62

    %

     

     

    63

    %

     

     

     

     

     

     

     

     

    Net cash used in investing activities

    $

    (31,700

    )

     

     

    (22,060

    )

     

    $

    (87,689

    )

     

    $

    (218,449

    )

    Net cash used in financing activities

    $

    (3,143

    )

     

     

    (38,338

    )

     

    $

    (37,666

    )

     

    $

    (158,514

    )

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20241105504314/en/

    Get the next $MPLN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MPLN

    DatePrice TargetRatingAnalyst
    6/26/2024$2.00Neutral
    Piper Sandler
    12/13/2022$3.00 → $2.00Buy → Neutral
    Citigroup
    7/12/2022$6.50Neutral
    Goldman
    12/20/2021$9.00 → $7.00Buy
    Citigroup
    11/11/2021$7.00 → $6.00Equal-Weight
    Barclays
    10/4/2021$9.00Buy
    Citigroup
    8/20/2021$9.00Buy
    Tigress Financial
    More analyst ratings

    $MPLN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Piper Sandler initiated coverage on MultiPlan with a new price target

      Piper Sandler initiated coverage of MultiPlan with a rating of Neutral and set a new price target of $2.00

      6/26/24 7:57:01 AM ET
      $MPLN
      Business Services
      Consumer Discretionary
    • MultiPlan downgraded by Citigroup with a new price target

      Citigroup downgraded MultiPlan from Buy to Neutral and set a new price target of $2.00 from $3.00 previously

      12/13/22 9:12:38 AM ET
      $MPLN
      Business Services
      Consumer Discretionary
    • Goldman initiated coverage on MultiPlan with a new price target

      Goldman initiated coverage of MultiPlan with a rating of Neutral and set a new price target of $6.50

      7/12/22 7:32:35 AM ET
      $MPLN
      Business Services
      Consumer Discretionary

    $MPLN
    SEC Filings

    See more
    • SEC Form 10-K filed by MultiPlan Corporation

      10-K - Claritev Corp (0001793229) (Filer)

      2/26/25 7:50:06 AM ET
      $MPLN
      Business Services
      Consumer Discretionary
    • MultiPlan Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Claritev Corp (0001793229) (Filer)

      2/25/25 6:21:17 AM ET
      $MPLN
      Business Services
      Consumer Discretionary
    • MultiPlan Corporation filed SEC Form 8-K: Other Events

      8-K - Claritev Corp (0001793229) (Filer)

      2/24/25 8:02:11 AM ET
      $MPLN
      Business Services
      Consumer Discretionary

    $MPLN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SVP, Chief Information Officer Kim Michael bought $249,588 worth of shares (40,000 units at $6.24), increasing direct ownership by 3% to 1,312,772 units (SEC Form 4)

      4 - MultiPlan Corp (0001793229) (Issuer)

      11/19/24 4:35:27 PM ET
      $MPLN
      Business Services
      Consumer Discretionary
    • SVP, Corp. Affairs/Strategy Mintz William B. bought $104,359 worth of shares (278,165 units at $0.38), increasing direct ownership by 14% to 2,206,736 units (SEC Form 4)

      4 - MultiPlan Corp (0001793229) (Issuer)

      8/8/24 4:30:55 PM ET
      $MPLN
      Business Services
      Consumer Discretionary
    • Pres., Chief Executive Officer Dalton Travis bought $185,000 worth of shares (500,000 units at $0.37), increasing direct ownership by 11% to 5,004,504 units (SEC Form 4)

      4 - MultiPlan Corp (0001793229) (Issuer)

      8/7/24 6:05:14 PM ET
      $MPLN
      Business Services
      Consumer Discretionary

    $MPLN
    Financials

    Live finance-specific insights

    See more
    • Claritev Reports Fourth Quarter and Full Year 2024 Results with Initial Guidance for Full Year 2025

      Q4 2024 Revenues of $232.1 million, Net Loss of $138.0 million and Adjusted EBITDA of $141.6 million Full Year 2024 Revenues of $930.6 million, Net Loss of $1,645.8 million and Adjusted EBITDA of $576.7 million Full Year 2025 Revenues guidance of (2)% to flat as compared to FY 2024 and FY 2025 Adjusted EBITDA % guidance of 62.5% to 63.5% Claritev Corporation ("Claritev" or the "Company") (NYSE:MPLN), formerly known as MultiPlan, a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the fourth quarter and full year ended December 31, 2024. Chairman, CEO and President Travis Dalt

      2/25/25 6:00:00 AM ET
      $MPLN
      Business Services
      Consumer Discretionary
    • MultiPlan Corporation Announces Fourth Quarter and Full Year 2024 Earnings Conference Call

      MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading provider of technology and data solutions that improve affordability, quality and transparency in healthcare, announced today that it will release its fourth quarter and full year 2024 financial results on Tuesday, February 25, 2025, and hold its conference call that morning at 8:00 am Eastern Time. To join the conference call, please pre-register using the link below. Participants who pre-register will receive a calendar invitation with call access details including a unique pin. Pre-registration may be completed at any time up to and following the call start time. To pre-register, go to: https://www.netroadsho

      1/28/25 8:30:00 AM ET
      $MPLN
      Business Services
      Consumer Discretionary
    • MultiPlan Reports Third Quarter 2024 Results and Updates 2024 Guidance

      – Q3 2024 Revenues of $230.5 million, Net Loss of $391.5 million (including a $361.6 million impairment of goodwill and indefinite-lived intangibles), and Adjusted EBITDA of $141.6 million – Identified potential medical cost savings of approximately $6.4 billion in Q3 2024, up 10% from Q3 2023 and up 3% from Q2 2024 MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading provider of data-driven cost management solutions that deliver transparency and promote fairness, quality and affordability to the U.S. healthcare industry, today reported financial results for the third quarter ended September 30, 2024 and updated its full-year 2024 guidance. CEO Travis Dalton said,

      11/5/24 6:00:00 AM ET
      $MPLN
      Business Services
      Consumer Discretionary

    $MPLN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by MultiPlan Corporation

      SC 13G/A - MultiPlan Corp (0001793229) (Subject)

      11/12/24 4:00:27 PM ET
      $MPLN
      Business Services
      Consumer Discretionary
    • Amendment: SEC Form SC 13G/A filed by MultiPlan Corporation

      SC 13G/A - MultiPlan Corp (0001793229) (Subject)

      11/4/24 3:13:44 PM ET
      $MPLN
      Business Services
      Consumer Discretionary
    • Amendment: SEC Form SC 13G/A filed by MultiPlan Corporation

      SC 13G/A - MultiPlan Corp (0001793229) (Subject)

      11/4/24 1:43:06 PM ET
      $MPLN
      Business Services
      Consumer Discretionary

    $MPLN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • ClearNote Health's Avantect® Pancreatic Cancer Test Now Available to Health Plan Members Accessing Claritev's National PPO Networks

      Latest agreement expands access to the PHCS and MultiPlan Networks ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced an agreement with Claritev, Inc. ("Claritev") (NYSE:CTEV), previously MultiPlan, Inc. (NYSE:MPLN), a technology and data insights company focused on making healthcare more affordable, transparent, and fair for all. As part of the agreement, ClearNote Health's Avantect® Pancreatic Cancer Test will now be available to health plan members accessing Claritev's national PHCS and MultiPlan Networks. While early detection has vastly improved survival rates for many types of cancer, pancreatic cancer is often diagnos

      3/12/25 8:03:00 AM ET
      $CTEV
      $MPLN
      Business Services
      Consumer Discretionary
    • Claritev Reports Fourth Quarter and Full Year 2024 Results with Initial Guidance for Full Year 2025

      Q4 2024 Revenues of $232.1 million, Net Loss of $138.0 million and Adjusted EBITDA of $141.6 million Full Year 2024 Revenues of $930.6 million, Net Loss of $1,645.8 million and Adjusted EBITDA of $576.7 million Full Year 2025 Revenues guidance of (2)% to flat as compared to FY 2024 and FY 2025 Adjusted EBITDA % guidance of 62.5% to 63.5% Claritev Corporation ("Claritev" or the "Company") (NYSE:MPLN), formerly known as MultiPlan, a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the fourth quarter and full year ended December 31, 2024. Chairman, CEO and President Travis Dalt

      2/25/25 6:00:00 AM ET
      $MPLN
      Business Services
      Consumer Discretionary
    • Claritev Provides Oracle Cloud HCM Customers with Actionable Insights for Healthcare Cost Optimization and Plan Design

      Claritev's Award-Winning Analytics Solution, BenInsights®, is Powered by Oracle Cloud and Now Available in the Oracle Cloud Marketplace Claritev Corporation ("Claritev" or the "Company") (NYSE:MPLN), formerly known as MultiPlan, a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, and an Oracle partner, announced today its analytics solution, BenInsights®, has achieved Integrated with Oracle Cloud Expertise and is now available in the Oracle Cloud Marketplace, offering added value to Oracle Cloud customers. The BenInsights platform enables visibility into benefit plan performance and compliance responsibilities for employers of

      2/21/25 8:00:00 AM ET
      $MPLN
      Business Services
      Consumer Discretionary

    $MPLN
    Leadership Updates

    Live Leadership Updates

    See more
    • MultiPlan Appoints Tiffani Misencik to Drive Strategic Growth

      Tiffani Misencik Named Chief Growth Officer in New Executive Leadership Role MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading provider of data-driven cost management solutions that deliver transparency and promote fairness, quality and affordability to the U.S. healthcare industry, today announced a new addition to its executive leadership team to support the next phase of the Company's strategic growth. Tiffani Misencik has been appointed Chief Growth Officer. In this newly created role, Misencik will oversee MultiPlan's sales and revenue growth strategy across all market segments. She will lead the company's efforts in client acquisition, client management, an

      10/22/24 2:00:00 PM ET
      $MPLN
      Business Services
      Consumer Discretionary
    • MultiPlan Makes Fortune's Best Workplaces in Health Care List for Second Year in a Row

      MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company"), a leading provider of technology and data-enabled cost management, payment, and revenue integrity solutions to the U.S. health care industry, is honored to announce it has been named in the 2024 Fortune Best Workplaces in Health Care™ List. based on its 2023-2024 Great Place to Work® Certification™ results. This is the second time MultiPlan has been named in the Best Workplaces in Health Care list. Earning a spot means that MultiPlan is one of the best companies to work for in the country. The Best Workplaces in Health Care list is based on analysis of survey responses from over 185,000 employees from Great Place To Work Cer

      9/12/24 8:30:00 AM ET
      $MPLN
      Business Services
      Consumer Discretionary
    • MultiPlan Announces CFO Transition

      MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions to the U.S. healthcare industry, announced today its CFO transition plan and named Doug Garis as EVP and CFO, effective August 5, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240731993142/en/Doug Garis named EVP and CFO of MultiPlan (Photo: Business Wire) Jim Head, who has served as EVP and CFO of MultiPlan since November 2021, will transition to a Strategic Advisor role to the Company through the end of the

      8/1/24 6:00:00 AM ET
      $DOOR
      $MPLN
      $ORCL
      $CERN
      Forest Products
      Basic Materials
      Business Services
      Consumer Discretionary

    $MPLN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Amendment: SEC Form 4 filed by SVP, Chief Information Officer Kim Michael

      4/A - MultiPlan Corp (0001793229) (Issuer)

      12/13/24 4:28:52 PM ET
      $MPLN
      Business Services
      Consumer Discretionary
    • SVP, Chief Information Officer Kim Michael bought $249,588 worth of shares (40,000 units at $6.24), increasing direct ownership by 3% to 1,312,772 units (SEC Form 4)

      4 - MultiPlan Corp (0001793229) (Issuer)

      11/19/24 4:35:27 PM ET
      $MPLN
      Business Services
      Consumer Discretionary
    • SVP, Chief Growth Officer Misencik Tiffani was granted 95,328 shares (SEC Form 4)

      4 - MultiPlan Corp (0001793229) (Issuer)

      10/16/24 5:01:01 PM ET
      $MPLN
      Business Services
      Consumer Discretionary